Delirium Tied to Increased Risk of Death in Critically Ill With Cancer
Critically ill patients with cancer who develop delirium have a higher risk of dying in the hospital or intensive care unit, a study suggests.
Diagnosis & Disease Information
Artificial Intelligence Can Predict Cancer Survival Using Data From a Single Consultation
Artificial intelligence can predict survival in cancer patients using information from a patient’s initial consultation with an oncologist, a study suggests.
Long-Term Data Support Frontline Avelumab and Axitinib for Advanced RCC
Combination avelumab and axitinib has shown long-term activity in previously untreated patients with advanced renal cell carcinoma.
Racial Disparities in Radiotherapy Regimens for Prostate and Breast Cancer
Black cancer patients are less likely than their White counterparts to receive shorter radiotherapy regimens, a study suggests.
ASTRO: Sexual Function After Brachytherapy Less Often Assessed in Women
Sexual function less likely to be assessed in women versus men undergoing brachytherapy for genitourinary cancers
Blood Test Shows Promise for Detecting Cancers Without Approved Screening Tests
A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.
Cost of Cancer Care Growing for Those With Private Insurance
A team of investigators examined the financial burden of breast, lung, colorectal, and prostate cancers for nonelderly adults with private insurance.
Follow-Up Confirms DFS Benefit With Pembrolizumab in Clear Cell RCC
Adjuvant pembrolizumab could be a new standard of care for patients with clear cell renal cell carcinoma at increased risk of recurrence after nephrectomy, according to researchers.
Adjuvant Nivolumab-Ipilimumab Failed to Improve DFS in Renal Cell Carcinoma
Nivolumab plus ipilimumab did not prolong disease-free survival, and 43% of patients discontinued treatment due to toxicities.
COSMIC-313: Triplet Prolongs PFS vs Doublet in Renal Cell Carcinoma
The PFS benefit was driven primarily by patients with intermediate-risk disease.
- Loading...
Loading...
Next post in Kidney Cancer
Loading... 
Loading...